Global Endovascular Treatment Devices Market is expected to grow at a CAGR of 7.3% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Endovascular Treatment Devices Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market.
The major key players of the market are as follows:
ALTURA MEDICAL (SUBSIDIARY OF LOMBARD MEDICAL)
BLOCKADE MEDICAL LLC (SUBSIDIARY OF BALT INTERNATIONAL)
BOLTON MEDICAL INC. (SUBSIDIARY OF VASCUTEK TERUMO)
BOSTON SCIENTIFIC CORP.
COOK GROUP INC.
CORDIS CORP. (SUBSIDIARY OF CARDINAL HEALTH INC.)
ENDOLUMINAL SCIENCES PTY LTD.
ENDOMED (SUBSIDIARY OF LEMAITRE VASCULAR)
JAPAN LIFELINE CO. LTD.
LEMAITRE VASCULAR INC.
LOMBARD MEDICAL TECHNOLOGIES
MICROVENTION (SUBSIDIARY OF TERUMO)
MICRUS ENDOVASCULAR (SUBSIDIARY OF JOHNSON & JOHNSON)
NELLIX INC. (SUBSIDIARY OF ENDOLOGIX)
TRIVASCULAR TECHNOLOGIES (SUBSIDIARY OF ENDOLOGIX INC.)
W.L. GORE AND ASSOCIATES
Scope of the Market
Thoracic Aortic Aneurysms Market
Risk Factors and Symptoms
Epidemiology and Economic Burden
Key Marketed and Pipeline Products
Current Challenges and Future Developments
Rest of the World (RoW)